Syneron Candela Newsletter // Edition 18
Welcome
First of all, I hope that your start to 2015 has been a happy and prosperous one. 2014 was an exciting year with new treatments for the VelaShape lll including cellulite and facial protocols, the addition of the fungal nail treatment for our Gentle laser devices and then the launch of the new PicoWay device at CCR in October. To start the New Year we have been working closely with Charlotte and her team at True Grace PR to secure even more great press coverage for the brand. Our first major event of the year was a hosted press event, to get the consumer press excited about our body treatments. This exciting day took place at the prestigious PHI clinic, Harley Street. Already producing positive consumer press stories, this event will help drive clients to your clinic. We revealed the results of our body beautiful survey, in which we asked 1000 British women to reveal exactly what they think and feel about their bodies. Read these results, as well as more about the press event, later on in this issue. We are really pleased for UltraShape® to be recognised as a breakthrough In non-invasive abdominal fat reduction thanks to its painless and effective ultrasound technology, by New-Beauty Magazine. Wishing you all the very best for 2015!
Michaela
Contents Latest News
UltraShape® Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment
PR & Marketing
Body Beautiful Press Event and Survey Results as well as Mentions in The Times, Hello, The Harley Street Journal and more...
Focus On...
UltraShape® Focussed Ultrasound Fat Cell Destruction for NonInvasive Body Contouring
Clinical Results
Body Contouring by Non-Invasive Transdermal Focused Ultrasound and Safety
Conferences & Events ACE, Pro Beauty, Aesthetic Medicine and many more...
Michaela Barker UK General Manager Syneron Candela UK Ltd
Contact Us
Get in touch with the team here with any questions or for further information about any of our products
PicoWay in Harley Street The first PicoWay picosecond tattoo removal device is installed and attracting a lot of attention at the PHI Clinic, Harley Street.
safest technology currently available for the removal of the broadest range of tattoo colours as well as benign pigmented lesions.
Dr Tapan Patel took delivery of the device in January and had already secured an extensive patient waiting list for treatments with the device.
Michaela Barker General Manager for Syneron Candela UK says……….
The PicoWay utilises two different wavelengths, namely the 532 nm and 1064 nm wavelengths, which enable a more effective and efficient clearing of a broader spectrum of tattoo colours. Picosecond technology is proving to be the most effective, efficient and
www.syneron-candela.co.uk
‘We are delighted to have such a prestigious clinic as our first outlet for this revolutionary device and are currently looking to broaden the availability of the PicoWay device, so patients throughout the UK can benefit from the excellent results it offers’
latest news
UltraShape® Wins NewBeauty Magazine Beauty Choice Award For Best Body-Contouring Treatment UltraShape Is Recognised As A Breakthrough In Non-Invasive Abdominal Fat Reduction Thanks To Its Painless And Effective Ultrasound Technology. NewBeauty Magazine awarded UltraShape® the “Best BodyContouring Treatment” in its annual 2014 Beauty Choice Awards. As a winner in the coveted “Beauty Game Changers” category, UltraShape is recognised for its innovative ultrasound-based treatment that painlessly and permanently destroys fat in the abdominal area where fat is most resistant to diet and exercise. Featured alongside an elite list of
outstanding aesthetic products, NewBeauty notes that UltraShape was chosen by a panel of thousands of readers, editors and beauty industry experts for its ability to deliver real, noticeable and highly customisable results “without surgery or hours spent in the gym”. “As the number of satisfied UltraShape users continues to grow, we are honoured to earn recognition from NewBeauty Magazine, further validating our leading position in the body shaping space”, said Dr. Shimon Eckhouse, Chairman of the Board of Directors for Syneron. “UltraShape represents the next generation in body-shaping with proven clinical outcomes and a superior safety profile, underscoring Syneron’s ongoing commitment to advancing treatment outcomes through technological innovation”. “What sets UltraShape apart from other body shaping solutions is its fast outcomes with results visible in often as little as 2 weeks post first treatment,” says Amit Meridor, Chief Executive Officer of Syneron. “With UltraShape’s customisable treatments, for the very first time physicians are able to truly sculpt instead of bulk heat or freeze fat. UltraShape is a painless solution for those who cannot get rid of stubborn fat resistant to diet and exercise”. The UltraShape System is the first and only non-invasive body shaping treatment that uses pulsed focused
ultrasound energy to precisely target subcutaneous fat, while keeping the surrounding tissue, vasculature, nerves and muscles intact. Unlike other body shaping technologies that use heat or freezing techniques, UltraShape uses a pure mechanical effect to destroy fat cells without inducing thermal damage. This unique feature of UltraShape technology results in a safe and comfortable treatment experience with no visible signs of treatment and no downtime. The newest fat-blasting treatment on the block, UltraShape, with over 300,000 procedures performed worldwide, was cleared by the United States Food and Drug Administration (FDA) 510(k) for non-invasive reduction of abdominal circumference via fat cell destruction in April of last year. About NewBeauty® NewBeauty® magazine is the definitive authority on all things beauty. Each issue of NewBeauty gives readers an in-depth look at the beauty industry’s latest products, cutting-edge innovations and breakthrough technologies. Whether it’s the latest high-powered skin care or in-office procedure, NewBeauty educates readers on the latest options for skin, face, hair, body, wellbeing and smile. The magazine’s comprehensive approach to its topics continues to solidify its reputation as the industry’s leading scientifically accurate, expert-driven and ethically balanced beauty resource.
Edition 18 // syneron candela newsletter // 2
pr & marketing
In the press
www.syneron-candela.co.uk
In the press
Edition 18 // syneron candela newsletter // 4
Press Event
Body Beautiful Press Event
It may only have been January, but Syneron Candela together with our PR partners at True Grace, hosted a press event, to get the consumer press excited about our body treatments. This exciting day took place at the prestigious PHI clinic, Harley Street. We are already producing positive consumer press stories and this event will help drive clients to your clinic. We created one large body event for consumer press offering them a one-stop-story hub, for their body features in leading magazines and newspapers. Timed for Spring / Summer issues, we were delighted to have four of the UK’s leading specialists to present both the facts and fix for each body concern.
The Speakers...
Body Perfecting: Fat, Cellulite, Skin Tightening / Body Contouring Dr Grant Hamlet Cosmetic Surgeon YBD Cosmetic Surgery
Skin Perfecting: Stretch Marks & Scars: Dr Sabika Karim Cosmetic Physician Revere Clinics
Tattoos: Jo Martin Clinical Director Mapperley Park Clinic
Leg Veins: Dr Tapan Patel PHI Clinic www.syneron-candela.co.uk
What the Press had to say... “What a great event. Top speakers who explained the benefits of the latest treatments brilliantly – and plenty of impressive before and after pictures, too.” Alice Hart-Davis, Beauty Journalist
“Thought the event was amazing! Dead interesting and useful. I’ve just included the stretch marks treatment in my round-up of ‘less-invasive versions of surgery/older nasty treatment’ piece.” Lynne Hyland, Beauty Editor Notebook mag, Sunday Mirror “Tattoo removal is a key issue which I wrote about a few year’s ago for the FT, but would be great to address in the Times Cosmetic Procedures I’m writing. I also found the information on stretch marks and skin laxity of great interest and the survey stats are really helpful.” Beatrice Aiden, Beauty Journalist “The new stretch mark treatment is particularly interesting to me and cellulite always a good one. I have covered off Vbeam a few times but not for scarring. I also like the idea of the treatments being suitable for all skin types.” Trish Leslie, Beauty Journalist: Bella, At Home etc “Great event at PHI Clinic. We understand first hand how much goes into organising an event like this and the ones that Charlotte and her team at TG organise are always well organised and attended - we’ll always continue to attend these as they always offer up valuable information on the cosmetic and beauty industry. “ Carl Frascina, Harley St Journal Edition 18 // syneron candela newsletter // 8
Press Event
www.syneron-candela.co.uk
Body beautiful survey
Edition 18 // syneron candela newsletter // 10
www.syneron-candela.co.uk
Edition 18 // syneron candela newsletter // 12
Focused on Results • Focused Ultrasound Fat Cell Destruction for Non-Invasive Body Contouring • Measurable and noticeable long-lasting results after just two weeks • Over 300,000 treatments performed worldwide www.syneron-candela.co.uk | info@syneron-candela.co.uk | Tel. 0845 5210698
This is not intended for use in the U.S. market. ©2014. All rights reserved. UltraShape, Syneron, the Syneron logo and elōs are trademarks of Syneron Medical Ltd. and may be registered in certain jurisdictions. elōs (electro-optical synergy) is a proprietary technology of Syneron Medical. Candela is a registered trademark of the Candela Corporation. PB84611EN
Edition 18 // syneron candela newsletter // 4
focus on
Mechanisms of Action The UltraShape V3 works by emitting acoustic waves of focused ultrasonic energy that converge into a confined focal volume targeting only subcutaneous fat at a controlled depth. Unlike traditional ultrasound technology, UltraShape V3’s energy transmits pulsed ultrasound, allowing control over temperature elevation and enabling fat destruction to occur instantly, selectively and mechanically (non-thermal).
The UltraShape Transducer: The heart of the UltraShape handpiece is a silver coated half dome shaped ceramic filled with medium matched to the human body impedance. When electrical voltage is applied to the silver coating, an electric field is created within the ceramics causing alteration in the ceramic thickness. This in turn creates pressure waves within the medium – these pressure waves are interpreted as sound waves and create the ultrasonic energy. (Figure 1)
(Figure 1) Focused Ultrasound: The rounded shape of the ceramic delivers low energy at the surface but provides a concentrated intensity of energy where the ultrasound waves converge at the focus. This focused energy allows targeting of defined tissues at a controlled depth, while leaving adjacent structures, such as skin, blood vessels, nerves, and muscles, unharmed (Figure 2). Pulsed Mode: The UltraShape transducer delivers the energy in bursts; this unique feature allows the generated heat to dissipate before the next pulse begins. This minimises the temperature rise (0.50 C) within and around the targeted tissues. The energy delivered is transformed into mechanical stresses that remain within the focus and exist only for the duration of energy delivery. This allows the targeting of tissues that are most susceptible to mechanical disruption, while more resistant structures remain intact. (Figure 2) Fat Clearance: The most common concern regarding non-invasive fat reduction is what happens to the destroyed fat cells. In clinical studies that have been conducted by Teitelbaum et al. (2007), the blood laboratory tests concluded that there were no clinically significant changes in lipid profile. During the UltraShape procedure, the membranes of the fat cells are disrupted. The fat cell content, primarily composed of triglycerides, is dispersed into the interstitial fluid among the cells and then transported by the body’s natural processes to the liver. The liver makes no distinction between fat coming from the procedure and fat originating from consumed food. Both are processed via the body’s natural mechanisms, the lymphatic, venous, and immune systems. Fat metabolites are processed in the liver in the same manner as fat originating from digested food.
Edition 18 // syneron candela newsletter // 14
Peer Reviewed Paper No.1 ABSTRACT: Body Contouring by Non-Invasive Transdermal Focused Ultrasound Moreno-Moraga et al, Lasers Surg Med. 2007 Apr; 39(4): 315-23 BACKGROUND & OBJECTIVES: The risks of currently available invasive procedures in body contouring motivate a need for safer, non-invasive technologies for improving the appearance of body silhouette. A new device has been developed that uses focused therapeutic ultrasound to reduce adipose tissue non-invasively. The aim of this study was to assess the efficacy and safety of a novel non-invasive focused ultrasound system (UltraShape Ltd, Tel Aviv, Israel) in reducing localised fat deposits to improve body contours. METHODS: A prospective study was conducted on 30 healthy patients. All patients underwent three treatments, at 1-month intervals, and were followed for 1 month after the last treatment. Areas treated were the abdomen, inner and outer thighs, flanks, inner knees, and breasts (males only). No other body contouring procedure was used during the study. Efficacy was determined by change in fat thickness, assessed by ultrasound measurements, and by circumference measurements. Weight change
was monitored to assess whether reduction in fat thickness or circumference was dependent on or independent of weight loss. Safety was determined by clinical findings, assays of serum triglycerides, and liver ultrasound evaluation for the presence of steatosis. RESULTS: All patients showed significant reduction in subcutaneous fat thickness within the treated area. The mean reduction in fat thickness after three treatments was 2.28+/-0.80 cm. Circumference was reduced by a mean of 3.95+/-1.99 cm. Weight was unchanged during the treatment and follow-up period. No adverse effects were observed. Before After
Abdomen before treatment and after treatment Before After
Outer thighs before treatment and after treatment CONCLUSION: This study shows the efficacy and safety of focused ultrasound, using the UltraShape contour I, as a non-invasive transdermal method for reducing unwanted fat deposits in the body. Multiple treatments combined with appropriate patient and treatment area selection can produce dramatic improvements in body contour.
www.syneron-candela.co.uk
clinical Results
Peer Reviewed Paper No.2 ABSTRACT: Safety and efficacy of UltraShape Contour I treatments to improve the appearance of body contours: multiple treatments in shorter intervals.
significant. Circumference reduction on day 112 positively correlated with patients’ subjective satisfaction scores.
Ascher B. Aesthet Surg J. 2010 Mar; 30 (2): 21724. BACKGROUND: The UltraShape Contour I System (CE 0344; UltraShape Ltd., Yoqneam, Israel) is a noninvasive fat reduction and body contouring system currently approved for use outside the United States that utilises focused ultrasound to selectively disrupt adipocytes. OBJECTIVE: To evaluate the clinical safety and efficacy of the Contour I system when the intervals between treatments are shortened. METHODS: Twenty-five healthy Caucasian women were selected from the patient population at two clinics in Paris, France, and received three 30- to 90-minute Contour I treatments in the abdominal region at two-week intervals. Safety parameters evaluated included adverse events, local skin reaction, and pain. Efficacy parameters evaluated included treatment area circumference, body weight, and comparison of before and after photos. Untreated thigh areas served as an internal control. Subjects were followed for 84 days after the last treatment (day 112).
36-year-old female before the first treatment (A, C) and after the third treatment (B, D). 7.5-cm reduction in waist circumference. CONCLUSION: Our data showed that successive Contour I treatments at two-week intervals were safe and tolerable.
RESULTS: No adverse events occurred. The majority of subjects (n = 23; approximately 90%) reported no pain. Mean midline circumference (2 cm below midline) was reduced by 2.47 cm (P < .001) on day 14 after the first Contour I treatment, 3.51 cm (P < .001) on day 56, and 3.58 cm (P < .001) on day 112. Peak midline circumference reduction was 3.12 cm on day 112. Most patients (n = 14; 63%) reported a positive change in body contour. Mean thigh circumference (the control area) was unchanged; the relative change between treated and untreated areas of the abdomen was significantly different at all time points. Circumference and weight reduction were significantly correlated (r = 0.42-0.71) at all time points; mean weight decrease was not statistically
Edition 18 // syneron candela newsletter // 16
conferences & events
Come see us at… Professional Beauty Excel, London Docklands 22nd and 23rd February We are on stand S42 and will have a full selection of our aesthetic devices available for you to see, whilst our friendly staff will be on hand to answer any of your queries
ACE Conference Business Design Centre, London
Dates For Your Diary... 22nd - 23 Feb
Professional Beauty Excel London
www.professionalbeauty.co.uk
7th - 8th March
ACE Business Design Centre London
www.aestheticsconference.com
7th and 8th March We are on stand 67 and with this event firmly aimed at the aesthetic/medical sector we will have our most advanced devices on show. If you were not able to make it to the launch of the PicoWay at CCR last October, here is your chance to see our latest addition to the Syneron Candela range.
3rd - 5th April
Aesthetic Medicine Olympia London
www.aestheticmed.co.uk
16th - 17th April
BMLA Hilton Metropole Hotel Brighton
www.bmlaconference.co.uk
17th - 18th April
BTEC Advanced Award Laser, Light & Associated Aesthetic Therapies 2013 validation by Edexcel allows us to change the ways in which we can deliver BTEC certification. So, less papers and assessment; The 5-day course is structured around daily practical sessions aimed at delivering demonstration and hands-on experience against the main range of systems most commonly used in medical and aesthetic dermatology applications. Experts from medicine and industry will deliver targeted lectures designed to extend knowledge arising from practical sessions and exercises. Tutorial support will ensure that the evidence is in place to support. Monday 27th April to Friday 1st May 2015 Mapperley Park Clinic NOTTINGHAM £2000 +VAT (£2400)
For more information or to book your place on a course call: 0115 969 0111 Email: training@mapperleypark.co.uk Web: www.mapperleypark.co.uk/training
www.syneron-candela.co.uk
Dentistry Show NEC Birmingham
www.thedentistryshow.co.uk
8th - 9th May
ASAP Radisson Blu Hotel Glasgow www.theasap.co.uk
4th - 7th June
FACE QE11 Conference Centre London www.faceconference.com
26th September
BCAM Church House Conference Centre London www.bcam.ac.uk
contact us
If you have any questions or require further information about any of our products or services please contact: Address: Syneron Candela UK Ltd Unit 42, Llantarnam Park, Cwmbran, South Wales, NP44 3AW Tel: 0845 521 0698 Fax: 0845 521 0699
Who to contact at Syneron Candela UK: Louise Cousins/ Sales Support Louise deals with enquiries and sales. If you’re unsure she can direct your enquiry to the right person or department.
Ian Risby / Service Manager
Along with his team Ian can help solve any technical problems or servicing issues.
Dianne Burkhill / Marketing Manager
General clinic marketing. For questions related to accessing Partners–Online and downloading marketing materials.
@syneron_candela
Email: info@Syneron-Candela.co.uk Web: www.Syneron-Candela.co.uk
facebook/SyneronMedical youtube/SyneronCandelaCorp linkedin/company/syneron
Did you know you can access archived copies of our newsletter?
Thank you for reading our newsletter! We hope you found it informative and enjoyable!
To read back issues click here
Edition 18 // syneron candela newsletter // 18